Delivery Order SPE2DX22D0099-SPE2D826FAA2B
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,946.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 3, 2025, for a ceiling value of $15,517.68 under a firm fixed price contract. This non-set-aside award represents a child delivery order issued against a larger indefinite delivery contract vehicle. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 6, 2025. As...
- The Defense Logistics Agency's Medical Supply Chain awarded a $13,542.99 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with completion due October 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The work will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,231.73 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with completion expected by October 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,907.53 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price, non-set-aside delivery order is performed in Conshohocken, Pennsylvania, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award reflects the company's role as a critical pharmaceutical and medical supply...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 3, 2025, with a ceiling value of $96,800.26. This firm fixed-price delivery order, with an ultimate completion date of October 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and work will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 3, 2025, with a ceiling value of $19,252.33. This firm fixed price delivery order, with an ultimate completion date of October 6, 2025, represents a child contract issued under a larger contract vehicle. The award was made through open competition with no set-aside designation. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,954.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's broader relationship with the federal government. The work will be performed at the company's corporate...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 14, 2025. This firm fixed price delivery order, which carries an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAA2BDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with a ceiling value of $12,730.32. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for ultimate completion on October 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through the standard federal procurement process. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical supply requirements through open competition and its comprehensive global pharmaceutical support vehicle make it well-positioned to serve the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 10/6/25 |